Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
This is a 3 months single centre clinical patient-oriented study to evaluate the prevalence
 and impairment in QOL of dermatologic diseases in patients hospitalised in internal medicine.

 Up to 200 patients hospitalised at the division of internal medicine for any reason are going
 to be offered participation by a patient information form given to patients at the time of
 admission, as well as oral information about the study. Written informed consent will be
 obtained by the investigators after patients have had adequate time to consider their
 participation in the study.

 Participating patients will be examined clinically for dermatologic pathologies at a single
 visit. In the case of signs of dermatologic disease, investigators are going to recommend
 further diagnostic procedures to the physician in charge and/or the referring physician,
 depending on the urgency of the suspected diagnosis. This procedure is meant to avoid giving
 referring physicians the impression that active patient acquisition for the department of
 Dermatology is an aim of this study. Diagnostic procedures that are performed upon suspicion
 of a specific dermatologic disease at the Division of Internal Medicine are going to be
 performed during the hospitalisation period. All other diagnostic or operative procedures are
 going to be advised to the referring physician.

 Study participants are going to be interviewed by the investigators about impairment in QOL
 of their illnesses. Two separate questionnaires are going to be filled in by each
 participant. For measurement of general QOL, the widely used SF-12 questionnaire (8
 questions) is going to be used. To measure specific impairment in QOL by dermatologic
 disease, participants are going to be asked to fill in the DLQI (Dermatology life quality
 index, 10 questions). Photographic documentation of specific identified lesions will be made
 and pictures stored exclusively in the secured electronic patient file (KISIM). Medication
 and all identified diseases will be noted. All diagnostically useful information is going to
 be recorded in the patient file and transmitted to the referring physician in the discharge
 letter.
Inclusion criteria: Patients will be eligible for enrolment if they fulfil the following
 criteria:

 1. Male or female patients, age ? 18 years of age and

 2. Hospitalised at the Division of Internal Medicine, University Hospital Zurich

 3. Patients must be able to give written informed consent before any trial-specific
 procedures are performed (see Section 12.2).

 Exclusion criteria: Patients will be excluded from the study if they fulfill any of the
 following criteria:

 1. Ability to communicate orally severely impaired due to any reason, namely illness or
 inability to speak German.

 2. Terminal patients or other patients where participation in a visit with oral and
 physical examination would represent an unreasonable exertion.

 3. Pregnant women